Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | LAP3 | P28838 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | NOS2 | P35228 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28977889 | 0.98 | SPHK1 (0.45) | SPHK1SPHK2CNR2OPRM1LMNA | |
| SCHEMBL4536662 | 0.98 | SPHK1 (0.45) | SPHK1SPHK2CNR2OPRM1LMNA | |
| Hydrochloric Acid SCHEMBL3722897 | 0.96 | SPHK1 (0.43) | SPHK1SPHK2CNR2OPRM1LMNA | |
| SCHEMBL6380455 | 0.90 | SPHK1 (0.42) | SPHK1SPHK2CNR2OPRM1LMNA | |
| Acetic Acid SCHEMBL11113366 | 0.89 | CNR2 (0.45) | CNR2MAPTGPR84 | |
| Nitric Acid SCHEMBL11104083 | 0.88 | CNR2 (0.38) | SPHK1SPHK2CNR2OPRM1TP53 | |
| Lactic Acid SCHEMBL11109148 | 0.86 | GPR84 (0.44) | CNR2MAPTGPR84 | |
| Acetic Acid SCHEMBL1123274 | 0.82 | GPR84 (0.42) | CNR2MAPTGPR84 | |
| Hydrochloric Acid SCHEMBL11114658 | 0.82 | NOS3 (0.31) | SPHK1SPHK2NOS3NOS1NOS2 | |
| SCHEMBL21908450 | 0.81 | PLA2G2C (0.42) | SPHK1SPHK2OPRM1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3817730-A1 | COMPOSITIONS AND METHODS OF TREATMENT | Blueberry Therapeutics Limited (GB) | 2021-05-12 | — | — | EP | disclosed |
| EP-3817729-A1 | COMPOSITIONS AND METHODS OF TREATMENT | Blueberry Therapeutics Limited (GB) | 2021-05-12 | — | — | EP | disclosed |
| WO-2020008196-A1 | COMPOSITIONS AND METHODS OF TREATMENT | BLUEBERRY THERAPEUTICS LIMITED (GB) | 2020-01-09 | — | — | WO | disclosed |
| WO-2020008195-A1 | COMPOSITIONS AND METHODS OF TREATMENT | BLUEBERRY THERAPEUTICS LIMITED (GB) | 2020-01-09 | — | — | WO | disclosed |
| WO-2019175873-A1 | COMPOUNDS AND USES FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS ASSOCIATE WITH OR AGGRAVATED BY IMPARED MITOPHAGY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-09-19 | — | — | WO | disclosed |
| EP-3432867-A1 | COMPOSITION AND METHODS OF TREATMENT | Blueberry Therapeutics Limited (GB) | 2019-01-30 | — | — | EP | disclosed |
| EP-3319640-A1 | COMPOSITION AND METHODS OF TREATMENT | Blueberry Therapeutics Limited (GB) | 2018-05-16 | — | — | EP | disclosed |
| WO-2017163091-A1 | COMPOSITION AND METHODS OF TREATMENT | BLUEBERRY THERAPEUTICS LIMITED (GB) | 2017-09-28 | — | — | WO | disclosed |
| WO-2017006112-A1 | COMPOSITION AND METHODS OF TREATMENT | BLUEBERRY THERAPEUTICS LIMITED (GB) | 2017-01-12 | — | — | WO | disclosed |
| EP-3049056-A1 | ANTIFUNGAL TOPICAL COMPOSITION AND METHODS OF TREATMENT | Blueberry Therapeutics Limited (GB) | 2016-08-03 | — | — | EP | disclosed |
| CN-101148452-A | Oral cavity articles, preparation method and application thereof | HAOWEI CO LTD (VG) | 2008-03-26 | — | — | CN | disclosed |
| CN-101148451-A | Oral cavity medicament and oral cavity nursing article | HAOWEI CO LTD (VG) | 2008-03-26 | — | — | CN | disclosed |
| CN-101147724-A | Medicine or sanitary product containing licorice flavone extraction for oral cavity | HAOWEI CO LTD (VG) | 2008-03-26 | — | — | CN | disclosed |
| EP-1644500-A2 | POLYCATIONIC COMPOSITIONS FOR CELLULAR DELIVERY OF POLYNUCLEOTIDES | Sirna Therapeutics, Inc. (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005007854-A2 | POLYCATIONIC COMPOSITIONS FOR CELLULAR DELIVERY OF POLYNUCLEOTIDES | SIRNA THERAPEUTICS, INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-0449872-B1 | ABSORBENT MATERIAL | LAPORTE INDUSTRIES LTD (GB) | 1995-07-26 | — | — | EP | disclosed |
| US-5109805-A | Litter | LAPORTE INDUSTRIES LIMITED (GB) | 1992-05-05 | — | — | US | disclosed |
| EP-0449872-A1 | ABSORBENT MATERIAL. | LAPORTE INDUSTRIES LTD (GB) | 1991-10-09 | — | — | EP | disclosed |
| WO-1990007273-A1 | ABSORBENT MATERIAL | LAPORTE INDUSTRIES LIMITED (GB) | 1990-07-12 | — | — | WO | disclosed |
| US-4062793-A | GUANIDO-HEXANES | BLENDAX-WERKE R. SCHNEIDER GMBH & CO. (DT) | 1977-12-13 | — | — | US | disclosed |